Login / Signup

Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia.

Yu-Shan HeMei YangGang LiuJian JiSu-Yun Qian
Published in: Pediatric pulmonology (2023)
Moxifloxacin was well tolerated and safe for treating SRMPP in children.
Keyphrases
  • young adults
  • early onset
  • intensive care unit
  • extracorporeal membrane oxygenation